High-end Analytical Tools to Meet the Latest Regulatory Requirements for Generic Peptides Published 2024-06-17 Download video MP4 360p Recommendations 15:19 Study for the Novel Energy Efficient Approach for Reclaiming Acetonitrile in Peptide Manufacturing 54:19 From 10 grams to several hundred - A case study in peptide GMP process development 26:11 Tailoring Control Strategies to Meet Specific Peptide Drug Substance Complexity 1:01:01 Increased protein coverage for high-quality peptides with streamlined, scalable sample prep workflow 12:43 How Japan's Priciest Shiitake Mushrooms Fuel The $740 Million Global Shiitake Industry 23:44 Elon Musk's Bionic Eyes Are Here. 04:44 Bienvenue chez PolyPeptide 1:42:42 Pufendorf Lectures 2024 Lisa Feldman Barrett - Day 2 - Constructing the Mind 06:52 PolyPeptide Group, Malmö, Sweden 23:06 Novel Branching Method for Solid Phase Peptide Synthesis 46:18 The Myths About Living With Dyspraxia 28:09 Developing the Toolbox for Sustainable Peptide Manufacturing, Jon Holbech Rasmussen , TIDES ASIA 14:45 Working in Public Relations | All About PR 18:31 Overcoming Oligonucleotide Manufacturing Challenges, Loïc Cornelissen, TIDES ASIA 16:17 How to Cope with Rumination: Don't Feed the “Demon” (Default Mode Network) 52:35 2024.06.14 PASS - Utility of RNA sequencing for the diagnosis and therapy of genetic disorders 21:53 Raw Material Control Strategy TIDES USA 2023, Eran Benjamin 01:20 PolyPeptide Braine-l'Alleud recrute 32:24 Chemical strategies in extending half-lives of therapeutic peptides, El Djouhar Rekai, TIDES ASIA Similar videos 1:44:40 Advancing Generic Drug Development: Translating Science to Approval - Day 1 – Keynote and Session 1 47:00 ISO 13485: The Perfect Fit for Peptide-Based In Vitro Diagnostics 50:27 Model-Integrated Evidence for Generic Drug Development – Session 1B 2:28:46 Advancing Generic Drug Development: Translating Science to Approval – Day 1 – Session 2 19:36 Strategies to Demonstrate Complex API Sameness (10of35) Complex Generics – Sep. 25-26, 2019 34:41 Complex Product Characterization/Analysis - Session 2A 1:47:19 Andrew Huberman: Focus, Controversy, Politics, and Relationships | Lex Fridman Podcast #435 57:11 Unmet needs in regulatory science for generic drugs 43:14 Introduction to Regulatory Science at the FDA 16:08 Andrew Isidoridy: Evaluating immunogenicity risk of complex peptide products 58:05 Best Practices for Topical Generic Product Development & ANDA Submission–Session 3, Closing Remarks 09:06 Advancing Generic Drug Development: Translating Science to Approval Keynote Address 14:58 Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop 14:50 Panel Discussion on Method Development / Validations for Non-traditional Analytical Methods 24:21 Regulatory Considerations in Demonstrating Complex API Sameness More results